Rabbi Elie Abadie, M.D., senior rabbi, Jewish Council of the Emirates and Affiliation of Gulf Jewish Communities.
Jonathan J. Bush, Jr., govt chair, Firefly Well being.
Amy Abernethy, M.D., Ph.D., former principal deputy commissioner and performing chief info officer, U.S. Meals and Drug Administration.
Deepak Chopra, M.D., founder, The Chopra Basis and founder, Chopra International.
Micah Aberson, govt vp, Sanford Well being.
George Church, Ph.D., founding core school and lead, Wyss Institute, Harvard College; professor of genetics, Harvard Medical College; professor of well being sciences and know-how, Harvard and Massachusetts Institute of Know-how.
Gina Agiostratidou, Ph.D., program director, Sort 1 diabetes program, The Leona M. and Harry B. Helmsley Charitable Belief.
Ellen Wright Clayton, M.D., J.D., Craig-Weaver Professor of pediatrics and professor of well being coverage, Middle for Biomedical Ethics and Society, Vanderbilt College Medical Middle and professor of regulation, Vanderbilt College of Legislation.
Rick Anderson, president and common supervisor, North America, DarioHealth.
Chelsea Clinton, D.Phil., M.P.H., vice chair, Clinton Basis.
Stéphane Bancel, CEO, Moderna.
Kelly L. Shut, co-founder and chair of the board, The diaTribe Basis.
Justin L. Barrett, Ph.D., president, Blueprint 1543, honorary professor of theology and the sciences, St. Andrews College, College of Divinity.
Francis S. Collins, M.D., Ph.D., director, U.S. Nationwide Institutes of Well being.
Nir Barzilai, M.D., The Rennert Chair of Growing old Analysis, professor of drugs and genetics and director, Nathan Shock Middle of Excellence within the Biology of Growing old, Albert Einstein Faculty of Drugs.
Cindy Crawford, mannequin and entrepreneur.
Marc Benioff, chair and CEO, Salesforce.
John F. Crowley, chair of the board and CEO, Amicus Therapeutics, Inc.
Paul Bloom, Ph.D., Brooks and Suzanne Ragen Professor of Psychology, Yale College.
Ray Dalio, founder, co-chair and co-chief info officer, Bridgewater Associates, New York Occasions best-selling creator of “Rules: Life & Work.”
Emma Bloomberg, founder and CEO, Murmuration.
Richard J. Davidson, Ph.D., professor of psychology and psychiatry, and founder and director of the Middle for Wholesome Minds, College of Wisconsin-Madison.
Albert Bourla, D.V.M., Ph.D., chair and CEO, Pfizer.
Grand Hospitaller, H.E. Dominique Prince de La Rochefoucauld-Montbel, Bailiff Grand Cross of Honour and Devotion in Obedience, The Sovereign Order of Malta.
Otis W. Brawley, M.D., Bloomberg Distinguished Professor of oncology and epidemiology, Johns Hopkins College.
Marilyn Glassberg, M.D., division chief of pulmonary drugs, important care and sleep drugs; senior director of medical analysis for technique and progress, division of inner drugs, College of Arizona Faculty of Drugs.
Dan Buettner, founder, Blue Zones.
Laurie H. Glimcher, M.D., president and CEO, Dana-Farber Most cancers Institute, Richard and Susan Smith professor of drugs, Harvard Medical College, director, Dana-Farber/Harvard Most cancers Middle.
Ronald A. DePinho, M.D., Distinguished College Professor and previous president, MD Anderson Most cancers Middle.
Dr. Jane Goodall, DBE, founder, the Jane Goodall Institute and U.N. Messenger of Peace.
Joseph M. DeVivo, president, hospital and well being techniques, Teladoc Well being.
Scott Gottlieb, M.D., resident fellow, American Enterprise Institute and 23rd commissioner, U.S. Meals and Drug Administration.
Spencer P. Eccles, co-founder and managing companion, The Cynosure Group.
Andre Goy, M.D., physician-in-chief of Oncology Companies, Hackensack Meridian Well being; chair, John Theurer Most cancers Middle; founding chair of Oncology, Hackensack Meridian College of Drugs.
Rev. Terrence P. Ehrman, C.S.C., Ph.D., visiting assistant instructing professor, division of theology, College of Notre Dame.
Kurt J. Griffin, M.D., Ph.D., Todd and Linda Broin Chair for Diabetes Analysis; director of medical trials, The Sanford Undertaking, Sanford Analysis; and affiliate professor, pediatric endocrinology, Sanford College of Drugs, College of South Dakota.
Michael E. Farkouh, M.D., Peter Munk Chair in Multinational Medical Trials; director, Coronary heart & Stroke/Richard Lewar Centre of Excellence; vice-chair, analysis and professor of drugs, division of drugs, College of Toronto.
Sanjay Gupta, M.D., award-winning chief medical correspondent, CNN and neurosurgeon.
Paul Farmer, M.D., Ph.D., Kolokotrones College professor and chair, division of world well being and social drugs, Harvard Medical College; co-founder and chief strategist, Companions In Well being.
Robert J. Hariri, M.D., Ph.D., founder, chair, and CEO, Celularity.
Anthony S. Fauci, M.D., director, Nationwide Institute of Allergy and Infectious Ailments, U.S. Nationwide Institutes of Well being.
Katherine Excessive, M.D., president, therapeutics, AskBio.
Judy Faulkner, founder and CEO, Epic.
Marc Hodosh, founder and co-host, “LIFE ITSELF.”
David Feinberg, M.D., vp, head of Google Well being, Google.
Donald Hoffman, Ph.D., professor emeritus of cognitive sciences, College of California, Irvine.
Rev. Kevin T. FitzGerald, S.J., Ph.D., John A. Creighton College Professor and chair, division of medical humanities, Creighton College.
Jacquelyn Kulinski, M.D., director of the preventive cardiology program and affiliate professor of drugs, Medical Faculty of Wisconsin.
Renée Fleming, soprano; arts and well being advocate; creative advisor, John F. Kennedy Middle for the Performing Arts.
Samarth Kulkarni, Ph.D., CEO, CRISPR Therapeutics.
Robert C. Garrett, CEO, Hackensack Meridian Well being.
Timothy A. Lash, president, West Well being Coverage Middle.
Rebekah E. Gee, M.D., CEO, Louisiana State College Well being Care Companies; former secretary, Louisiana Division of Well being.
William W. Li, M.D., president, medical director and CEO, The Angiogenesis Basis.
Debra Houry, M.D., M.P.H., director, Nationwide Middle for Harm Prevention and Management, U.S. Facilities for Illness Management and Prevention.
Peter Libby, M.D., cardiovascular specialist, Brigham and Ladies’s Hospital and Mallinckrodt Professor of drugs, Harvard Medical College.
Ryan Howard, founder and CEO, 100Plus.
Dan Liljenquist, senior vp and chief technique officer, Intermountain Healthcare.
Mark Hyman, M.D., head of technique and innovation, Cleveland Clinic Middle for Purposeful Drugs.
Shelley Lyford, president and CEO, Gary and Mary West Basis.
Elder William Ok. Jackson, M.D., Common Authority Seventy, The Church of Jesus Christ of Latter-day Saints.
Peter Marks, M.D., Ph.D., director, Middle for Biologics Analysis and Analysis, U.S. Meals and Drug Administration.
Jo Ann Jenkins, CEO, AARP.
Brandon Marshall, NFL athlete, co-founder, Undertaking 375 and founder, Home of Athlete.
Henry Ji, Ph.D., chair, president and CEO, Sorrento Therapeutics.
Mark McClellan, M.D., Ph.D., director, Duke-Robert J. Margolis, M.D., Middle for Well being Coverage, and the Robert J. Margolis, M.D., Professor of Enterprise, Drugs, and Coverage, Duke College.
Thupten Jinpa, Ph.D., president, Compassion Institute.
Gary Mendell, founder and CEO, Shatterproof.
Carl June, M.D., the Richard W. Imprecise Professor in Immunotherapy and director of the Middle for Mobile Immunotherapies, Perelman College of Drugs; director of the Parker Institute for Most cancers Immunotherapy, College of Pennsylvania.
Jamie Metzl, J.D., Ph.D., founder and chair, OneShared.World.
Cigall Kadoch, Ph.D., professor, Dana-Farber Most cancers Institute and Harvard Medical College; founder, Foghorn Therapeutics.
Matthew May, Ph.D., professor and director, Hugh Kaul Precision Drugs Institute, College of Alabama at Birmingham.
Dean Kamen, president, DEKA R&D, chair ARMI, and founder, FIRST®.
Rosalind Picard, Sc.D., professor, MIT Media Lab; chief scientist and chair, Empatica.
Allen J. Karp, govt vp, healthcare administration and transformation, Horizon Blue Cross Blue Defend of New Jersey.
Renato Poletti, president, Science and Religion (STOQ) Basis and president, Basis for Heritage and Cultural and Inventive Actions of the Church.
Kerry Kennedy, president, Robert F. Kennedy Human Rights.
Cardinal Gianfranco Ravasi, president, Pontifical Council for Tradition.
Stephen Ok. Klasko, M.D., president, Thomas Jefferson College, CEO, Jefferson Well being.
Elder Dale G. Renlund, M.D., Quorum of the Twelve Apostles, The Church of Jesus Christ of Latter-day Saints.
Aaron J. Kowalski, Ph.D., president and CEO, JDRF Worldwide.
David C. Rhew, M.D., chief medical officer and vp of healthcare, Worldwide Business Enterprise, Microsoft.
Maria Millan, M.D., president and CEO, California Institute for Regenerative Drugs.
Walter Ricciardi, M.D., full professor in hygiene, Università Cattolica del Sacro Cuore, Rome; president, Mission Board for Most cancers of the European Fee; president, World Federation of Public Well being Associations.
Princess Dina Mired, speedy previous president, Union for Worldwide Most cancers Management; patron of SIOP; honorary president of EORTC; particular envoy for NCD’s Important Methods; member of WHO Knowledgeable Group for the Elimination of Cervical Most cancers.
Sheri L. Robb, Ph.D., professor, Indiana College College of Nursing.
William C. Mobley, M.D., Ph.D., affiliate dean for neurosciences initiatives, and interim director of the Sanford Institute for Empathy and Compassion, division of neurosciences, College of California San Diego.
Robert S. Rosenson, M.D., Director of Metabolism and Lipids, professor of drugs and cardiology, Icahn College of Drugs at Mount Sinai.
Dariush Mozaffarian, M.D., Dr.P.H., dean, Friedman College of Vitamin Science and Coverage, Tufts College.
Frank J. Sasinowski, J.D., M.P.H., director, Hyman, Phelps & McNamara.
Michael Murray, Ph.D., president, Arthur Vining Davis Foundations.
Roy Schoenberg, M.D., M.P.H., president and co-CEO, Amwell.
Julien Musolino, Ph.D., affiliate professor, division of psychology, Rutgers College.
John Sculley, managing companion, Sculley Advisors.
David B. Nash, M.D., founding dean emeritus and the Raymond C. and Doris N. Grandon Professor of Well being Coverage, Jefferson Faculty of Inhabitants Well being.
Stephen Shaya, M.D., managing director, Akkad Holdings; govt servant chief, J&B Medical.
Timothy O’Connor, Ph.D., Mahlon Powell Professor of Philosophy, Indiana College.
Jerrell W. Shelton, chair, president and CEO, Cryoport.
Emmanuel “Manny” Ohonme, president and CEO, Samaritan’s Ft Worldwide.
Andrew C. von Eschenbach, M.D., president, Samaritan Well being Initiatives; former Commissioner U.S. Meals and Drug Administration and 12th Director, Nationwide Most cancers Institute.
Cardinal Pietro Parolin, secretary of state, Vatican.
David A. Pearce, Ph.D., president of innovation and analysis, Sanford Well being.
Warren J. von Eschenbach, Ph.D., affiliate vp and assistant provost; affiliate instructing professor, division of philosophy and division of data know-how, analytics & operations, College of Notre Dame.
Andrew Pecora, M.D., CEO, Outcomes Matter Improvements and director, Celularity.
Jill Weimer, Ph.D., senior director of therapeutic improvement, Sanford Analysis.
Joe Perry, lead guitarist, GRAMMY® Award-winning songwriter and co-founder of the American Rock and Roll Band, Aerosmith.
Michael R. Yeaman, Ph.D., professor and chief of molecular drugs, UCLA College of Drugs; director, Institute for An infection & Immunity, Lundquist Institute at Harbor-UCLA; chair, medical sciences, Guthy-Jackson Charitable Basis.
William Shrank, M.D., chief medical and company affairs officer, Humana.
Shaykh Asim Yusuf, M.B., Ch.B., chair, British Board of Students and Imams and fellow, Royal Faculty of Psychiatrists.
Bernard Siegel, J.D., govt director, Regenerative Drugs Basis.
David A. Sinclair, Ph.D., professor, division of genetics and co-director of the Paul F. Glenn Middle for Biology of Growing old Analysis, Harvard Medical College.
Robin L. Smith, M.D., founder, president, and chair, Cura Basis and Stem for Life; vp and director, Science and Religion (STOQ) Basis.
Rudolph Tanzi, Ph.D., Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical College.
Edward A. Tenthoff, managing director, senior biotechnology analysis analyst, Piper Sandler and Firms.
Cristian Tomasetti, Ph.D., affiliate professor of oncology and biostatistics, Johns Hopkins College of Drugs and Bloomberg College of Public Well being.
Monsignor Tomasz Trafny, head of science and religion division, Pontifical Council for Tradition, and common secretary, Science and Religion (STOQ) Basis.
Donato J. Tramuto, founder and chair, Well being eVillages; founder and chair, Tramuto Basis; creator and well being care activist.
Stephen Trzeciak, M.D., professor, chair and chief of drugs, Cooper College Well being Care, Cooper Medical College of Rowan College.
Monsignor Dario Edoardo Viganò, vice chancellor, Pontifical Academy of Sciences and Pontifical Academy of Social Sciences.